Search

Search Constraints

You searched for: Author/Creator Penza, Sam

Search Results

1. A phase 1 study of vorinostat maintenance after autologous transplant in high-risk lymphoma. Issue 4 (April 2015)

2. Comparison of fixed dose reduced-intensity conditioning with fludarabine and busulfan to PK-guided busulfan AUC (FluBu4K) in hematopoietic stem cell transplant for AML/MDS. Issue 4 (21st March 2021)

3. Early versus delayed autologous stem cell transplant in patients receiving novel therapies for multiple myeloma. Issue 8 (August 2013)

4. Flavopiridol can be safely administered using a pharmacologically derived schedule and demonstrates activity in relapsed and refractory non‐Hodgkin's lymphoma. Issue 1 (30th September 2013)

5. Lower dose of antithymocyte globulin does not increase graft-versus-host disease in patients undergoing reduced-intensity conditioning allogeneic hematopoietic stem cell transplant. Issue 4 (April 2015)

6. Outcomes associated with allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma in the era of novel agents. (18th January 2023)

8. Psychosocial risk predicts high readmission rates for hematopoietic cell transplant recipients. (November 2018)

9. Tocilizumab for steroid refractory acute graft-versus-host disease. Issue 1 (2nd January 2016)